Abiopharma

🔍 Ciongoli Adam G. (Executive)

Company: Fox Corp (FOX)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Acquired 128 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 26,883.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4
• Acquired 122 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,791.00 | transaction_form_type: 4 | Footnotes: F1, F2, F5, F5, F4
• Acquired 142 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 30,007.00 | transaction_form_type: 4 | Footnotes: F1, F2, F6, F6, F4
• Acquired 131 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 27,569.00 | transaction_form_type: 4 | Footnotes: F1, F2, F7, F7, F4

Footnotes:

• F1: Each restricted stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.
• F2: Represents dividend equivalents accrued with respect to restricted stock units.
• F3: The restricted stock units vested one-third on June 30, 2024, one-third on June 30, 2025 and the remainder of the award will vest on June 30, 2026.
• F4: Represents the aggregate number of restricted stock units with respect to a specific grant that are held by the Reporting Person, including dividend equivalents accrued that vest on the same terms as the respective underlying restricted stock units.
• F5: The restricted stock units vested one-third on August 15, 2024, one-third on August 15, 2025 and the remainder of the award will vest on August 15, 2026.
• F6: The restricted stock units vested one-third on August 15, 2025, will vest one-third on August 15, 2026 and the remainder of the award will vest on August 15, 2027.
• F7: The restricted stock units will vest one-third on each of August 15, 2026, August 15, 2027 and August 15, 2028.